Preview

Medical Immunology (Russia)

Advanced search

INFLUENCE OF CYCLOFERON ON THE CELLULAR SUSCEPTIBILITY TO INTERFERON-α2 IN VITRO IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN– BARR VIRUS

https://doi.org/10.15789/1563-0625-2018-6-865-870

Abstract

Our aim was to study the effect of cycloferon on in vitro susceptibility of peripheral blood leukocytes to interferon-α2 in children with infectious mononucleosis in acute phase caused by Epstein-Barr virus (EBV).

 Materials and methods were as follows: the study included 23 children 4 to 6 years of age admitted in acute period of infectious mononucleosis. The control group consisted of 15 healthy children of the same age group. In vitro susceptibility of peripheral blood leukocytes to interferon-α2 was determined by the method of L.M. Kurtasova (2007).
Four types of in vitro response of peripheral blood leukocytes to interferon-α2 upon induction by cycloferon have been revealed in both healthy children and patients with EBV-positive infectious mononucleosis. Differences in occurrence rates of these 4 types of reactions have been found among patients with EBVinfection, in comparison with the group of healthy children. There was no regular dose-dependent changes in susceptibility of peripheral blood  leukocytes to interferon-α2 in vitro after cycloferon induction in the group of children with EBV-infection. depending on the dose, which have been revealed in healthy children.

About the Authors

L. M. Kurtasova
V. Voyno-Yasenetsky Krasnoyarsk State Medical University Krasnoyarsk Regional Center for Prevention and Control of AIDS
Russian Federation

PhD, MD (Medicine), Professor, Department of Clinical Immunology

660022, Russian Federation, Krasnoyarsk, Partizan Zheleznyak, str., 1.
Phone: 7 (391) 220-06-28.
Fax: 7 (391) 221-16-38



N. A. Shakina
Krasnoyarsk Regional Center for Prevention and Control of AIDS
Russian Federation

PhD (Medicine), Doctor for Clinical Diagnostics, Department of Immunological Research



A. R. Smidt
Krasnoyarsk Regional Center for Prevention and Control of AIDS
Russian Federation
Deputy Medical Director


L. A. Ikkes
V. Voyno-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Postgraduate Student, Department of Pediatric Infections



References

1. Богомолов С.В. Система интерферона: современные представления о структуре, организации и роли в реализации иммунитета // Инфекционные болезни, 2009. Т. 7, № 1. С. 49-53. [Bogomolov S.V. The interferon system: modern ideas of its structure, organization and role in realization of immunity. Infektsionnye bolezni = Infectious Diseases, 2009, Vol. 7, no. 1, pp. 49-53. (In Russ.)]

2. Гончарова Е.В., Сенюта Н.Б., Смирнова К.В., Щербак Л.Н., Гурцевич В.Э. Вирус Эпштейна–Барр (ВЭБ) в России: инфицированность населения и анализ вариантов гена LMP1 у больных ВЭБ-ассоциированными патологиями и у здоровых лиц // Вопросы вирусологии, 2015. Т. 60, № 2. С. 11-17. [Goncharova E.V., Senyuta N.B., Smirnov K.V., Shcherbak L.N., Gurtsevich V.E. Epstein–Barr virus (EBV) in Russia, the infection of the population and the analysis of gene LMP1 variants at the patients with EBV-associated disease and at healthy patients. Voprosy virusologii = Problems of Virology, 2015, Vol. 60, no. 2, pp. 11-17. (In Russ.)]

3. Ершов Ф.И., Наровлянский А.Н. Использование индукторов интерферона при вирусных инфекциях // Вопросы вирусологии, 2015. Т. 60, № 2. С. 5-10. [Ershov F.I., Narovlyansky A.N. Usage of interferon inducers during viral infections. Voprosy virusologii = Problems of Virology, 2015, Vol. 60, no. 2, pp. 5-10. (In Russ.)]

4. Львов Н.Д., Дудукина Е.А. Ключевые вопросы диагностики Эпштейна–Барр вирусной инфекции // Инфекционные болезни. Журнал для непрерывного медицинского образования врачей, 2013. № 3. С. 24-32. [Lvov N.D., Dudukina E.A. Key questions of the Epstein–Barr virus infection diagnostics. Infektsionnye bolezni. Zhurnal dlya nepreryvnogo meditsinskogo obrazovaniya vrachey = Infectious Diseases. Journal of Continuing Medical Education for Physicians, 2013, no. 3, pp. 24-32. (In Russ.)]

5. Оспельникова Т.П. Роль интерферона при гриппе и генитальном герпесе // Вопросы вирусологии, 2013. № 5. С. 4-10. [Ospelnikova T.P. The role of interferons in the socially important human viral diseases. Voprosy virusologii = Problems of Virology, 2013, Vol. 5, no. 5, pp. 4-11. (In Russ.)]

6. Патент 2293988 Российской Федерации. Способ оценки чувствительности к интерферону у больных раком почки / Л.М. Куртасова, Е.А. Шкапова, А.А. Савченко, А.И. Крыжановский, Р.А. Зуков, Н.В. Рачкова № 2005 1006.10; Заявл. 11.01.05; Опубл. 20.02.07, Изобретения. Полезные модели. 2007, Бюл., № 5. 4 с. [Patent 2293988 of Russian Federation. A method of evaluation of susceptibility to interferon at patients with clear cell carcinoma / L.M. Kurtasova, E.A. Shkapova, A.A. Savchenko, A.I. Krizhanovsky, R.A. Zukow, N.V. Rachkova No. 2005 1006.10; Stated. 11.01.05; Published. 20.02.07, Inventions. Utility Models. 2007 Bull., No. 5. 4 p].

7. Разгуляева А.В., Уханова О.П., Безроднова С.М. Современные представления об этиологии, патогенезе, клинике и лечении инфекционного мононуклеоза у детей // Наука. Инновации. Технологии, 2012. Т. 78, № 1. С. 222-227. [Razgulyaeva A.V., Ukhanova O.P., Bezrodnova S.М. Modern ideas about the etiology, pathogenesis, clinic and treatment of infectious mononucleosis in children. Nauka. Innovatsii. Tekhnologii = Science. Innovation. Technologies, 2012, Vol. 78, no. 1, pp. 222-227. (In Russ.)]

8. Шведова Н.М., Михайлова Е.В., Цека Ю.С., Чудакова Т.К. Инфекционный мононуклеоз у детей: клинико-лабораторное обследование и экономическая эффективность применения иммунокорректоров // Саратовский научно-медицинский журнал, 2013. Т. 9, № 3. С. 512-517. [Shvedova N.M., Mikhailova E.V., Tseka Yu.S., Chudakova T.K. Infectious mononucleosis in children: clinical and laboratory examination and costeffectiveness of immunocorrectors. Saratovskiy nauchno-meditsinskiy zhurnal = Saratov Journal of Medical Scientific Research, 2013, Vol. 9, no. 3, pp. 512-517. (In Russ.)]

9. de Sole P., Lippa S., Lixxarru G. Whole blood chemiluminescence: a new technical approach to access oxygen-dependent microbial activity of granulocytes. J. Clin. Lab. Autom., 1983, Vol. 3, pp. 391-400.

10. Odumade O.A., Hogqnist K.A., Balfour H.H. Progress and problems in understanding and managing primary Epstein–Barr virus in fections. Clin. Microbiol. Rev., 2011, Vol. 24, pp. 193-209.


Review

For citations:


Kurtasova L.M., Shakina N.A., Smidt A.R., Ikkes L.A. INFLUENCE OF CYCLOFERON ON THE CELLULAR SUSCEPTIBILITY TO INTERFERON-α2 IN VITRO IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN– BARR VIRUS. Medical Immunology (Russia). 2018;20(6):865-870. (In Russ.) https://doi.org/10.15789/1563-0625-2018-6-865-870

Views: 2457


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1563-0625 (Print)
ISSN 2313-741X (Online)